Literature DB >> 25194184

Endoscopic treatment: the past, the present and the future.

E M H Mathus-Vliegen1.   

Abstract

The obesity epidemic asks for an active involvement of gastroenterologists: many of the co-morbidities associated with obesity involve the gastrointestinal tract; a small proportion of obese patients will need bariatric surgery and may suffer from surgical complications that may be solved by minimally invasive endoscopic techniques; and finally, the majority will not be eligible for bariatric surgery and will need some other form of treatment. The first approach should consist of an energy-restricted diet, physical exercise and behaviour modification, followed by pharmacotherapy. For patients who do not respond to medical therapy but are not or not yet surgical candidates, an endoscopic treatment might look attractive. So, endoscopic bariatric therapy has a role to play either as an alternative or adjunct to medical treatment. The different endoscopic modalities may vary in mechanisms of action: by gastric distension and space occupation, delayed gastric emptying, gastric restriction and decreased distensibility, impaired gastric accommodation, stimulation of antroduodenal receptors, or by duodenal exclusion and malabsorption. These treatments will be discussed into detail.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aspire bariatrics system; Botulinum toxin A; Duodenojejunal bypass liner; Duodenojejunal bypass sleeve; Endoscopy; Gastric bubble; Gastric stapling; Gastric suturing; Intragastric balloons

Mesh:

Year:  2014        PMID: 25194184     DOI: 10.1016/j.bpg.2014.07.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  10 in total

Review 1.  Current status of intragastric balloon for obesity treatment.

Authors:  Seung Han Kim; Hoon Jai Chun; Hyuk Soon Choi; Eun Sun Kim; Bora Keum; Yoon Tae Jeen
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

2.  Elipse™, a Procedureless Gastric Balloon for Weight Loss: a Proof-of-Concept Pilot Study.

Authors:  Evzen Machytka; Ram Chuttani; Martina Bojkova; Tomas Kupka; Marek Buzga; Kathryn Stecco; Samuel Levy; Shantanu Gaur
Journal:  Obes Surg       Date:  2016-03       Impact factor: 4.129

3.  Effect of the EndoBarrier Device: a 4-Year Follow-up of a Multicenter Randomized Clinical Trial.

Authors:  Selwyn van Rijn; Yvonne G M Roebroek; Charlotte de Jonge; Jan Willem M Greve; Nicole D Bouvy
Journal:  Obes Surg       Date:  2019-04       Impact factor: 4.129

4.  Endoscopic Treatment for Obesity: New Emerging Technology Trends.

Authors:  Seung Han Kim; Hoon Jai Chun
Journal:  Gut Liver       Date:  2015-07       Impact factor: 4.519

5.  A Magnetic Soft Endoscopic Capsule-Inflated Intragastric Balloon for Weight Management.

Authors:  Thanh Nho Do; Khek Yu Ho; Soo Jay Phee
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

6.  Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014.

Authors:  L Angrisani; A Santonicola; P Iovino; A Vitiello; N Zundel; H Buchwald; N Scopinaro
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

7.  Is Endoscopy Really Necessary for Placing Intragastric Balloons?

Authors:  Elisabeth M H Mathus-Vliegen
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

8.  Short-term outcomes of the new intragastric balloon End-Ball® for treatment of obesity.

Authors:  Marek Buzga; Tomas Kupka; Milan Siroky; Habib Narwan; Evzen Machytka; Pavol Holeczy; Zdeněk Švagera
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2016-11-29       Impact factor: 1.195

9.  Ischemic Renal Injury Complicating Intragastric Balloon Insertion.

Authors:  Emad S Aljahdli
Journal:  ACG Case Rep J       Date:  2018-02-28

10.  Gastric outlet obstruction secondary to orbera intragastric balloon.

Authors:  Sharnice A Koek; Jack Hammond
Journal:  J Surg Case Rep       Date:  2018-10-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.